Kymera Therapeutics, Inc.

KYMR · XNAS

CIK 1815442fmd_15Z6766MHY6T2ZR7KJDE8GNFWCManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2019 to Sep 30, 2026, 29 periods

Ratios computed from the standardized statements. Select a value to open its proof.